MacroGenics, Inc.

NASDAQ:MGNX

Biotechnology

Healthcare
$1.98 +2.02%

+$0.08 today

Market cap
$126.54M
Beta
1.20
P/E (TTM)
-3.6
EPS (TTM)
-$1.11
52W Low $1.19High $4.64

Volume 0.93M

Average 0.98M

Income Statement

Follow revenue through to earnings.

Revenue

$149.50M

FY 2025 · Annual

+0.8% YoY

Operating Income

-$72.84M

FY 2025 · Annual

Net Income

-$74.62M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue75.64M150.02M57.19M148.34M149.5M
Cost of Revenue2.65M7.38M8.22M12.3M43.18M
Gross Profit72.99M142.63M48.97M136.04M106.32M
Gross Margin96.5%95.1%85.6%91.7%71.1%
Research & Development214.58M207.03M166.58M177.19M140M
Selling, General & Admin63.01M58.95M52.19M71.05M39.16M
Operating Expenses275.79M264.05M217.22M246.62M179.16M
Depreciation & Amortization11.26M11.87M9.65M7.54M7.17M
EBITDA(190.86M)(107.89M)2.02M(57.37M)(59.61M)
EBITDA Margin-252.3%-71.9%3.5%-38.7%-39.9%
Operating Income(202.8M)(121.42M)(168.24M)(110.58M)(72.84M)
Operating Margin-268.1%-80.9%-294.2%-74.5%-48.7%
Interest Income680K1.7M9.69M9.42M3.4M
Interest Expense001.43M1.12M8.51M
Other Income / Expenses680K1.66M159.19M44.56M(2.45M)
Income Before Tax(202.12M)(119.76M)(9.06M)(66.02M)(75.29M)
Pre-Tax Margin-267.2%-79.8%-15.8%-44.5%-50.4%
Income Tax Expense000944K(672K)
Net Income(202.12M)(119.76M)(9.06M)(66.97M)(74.62M)
Net Margin-267.2%-79.8%-15.8%-45.1%-49.9%
EPS (Basic)(3.18)(1.95)(0.15)(1.07)(1.18)
EPS (Diluted)(3.18)(1.95)(0.15)(1.07)(1.18)
Weighted Avg Shares59.94M61.41M61.93M62.62M63.16M
Weighted Avg Shares (Diluted)59.94M61.43M61.93M62.62M63.16M

MGNX Earnings Waterfall · TTM

NASDAQ:MGNX · Revenue to Net Income

Key Ratios

EPS$-1.10
Gross Margin62.6%
Net Margin-87.8%
P/E Ratio-0.5
P/S Ratio4.0

Analysis

$157.1M of revenue converted into -$70.4M of net income for the selected period. Gross margin is 62.6% and net margin is -87.8%, showing how much revenue survives after costs and taxes. EPS is $-1.10, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
3Initial statement of beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026

How much revenue does MGNX generate?

MacroGenics, Inc. (MGNX) reported $149.50M of revenue in fiscal 2025.

Is MGNX profitable?

MacroGenics, Inc. (MGNX) reported -$74.62M of net income, with a net margin of -49.9%.